KORU Medical Systems, Inc. (NASDAQ:KRMD – Get Free Report) was the target of a large decline in short interest in December. As of December 31st, there was short interest totalling 372,600 shares, a decline of 12.6% from the December 15th total of 426,400 shares. Based on an average trading volume of 67,100 shares, the days-to-cover ratio is currently 5.6 days. Currently, 0.9% of the shares of the stock are short sold.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on KRMD. Canaccord Genuity Group raised their price objective on KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Craig Hallum raised their price target on KORU Medical Systems from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Friday. Lake Street Capital boosted their price objective on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research report on Tuesday, January 14th. Finally, Piper Sandler raised their target price on shares of KORU Medical Systems from $3.00 to $3.50 and gave the company an “overweight” rating in a report on Thursday, November 14th. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, KORU Medical Systems presently has an average rating of “Buy” and a consensus target price of $4.50.
Check Out Our Latest Stock Report on KRMD
Institutional Inflows and Outflows
KORU Medical Systems Stock Performance
NASDAQ KRMD opened at $4.09 on Friday. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. KORU Medical Systems has a fifty-two week low of $1.98 and a fifty-two week high of $4.60. The business has a fifty day moving average of $3.82 and a 200-day moving average of $2.97. The stock has a market cap of $187.49 million, a price-to-earnings ratio of -16.36 and a beta of 0.45.
About KORU Medical Systems
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Read More
- Five stocks we like better than KORU Medical Systems
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Manufacturing Stocks Investing
- Oilfield Leader SLB: An AI Name You Need to Know
- Using the MarketBeat Dividend Tax Calculator
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.